#

iManageCancer event at MASCC/ISOO meeting in Vienna on June 28th

May 23, 2018

iManageCancer warmly invites all attendees of MASCC to come to a special workshop to find out more about the healthcare apps developed by the consortium.

The workshop is being held at 5.10pm on 28th June in the Schubert 6 Room at the MASCC/ISOO International Symposium on Supportive Care in Cancer meeting in Vienna.

Self-Management apps to empower cancer patients

The event will give attendees the opportunity to learn about the latest in self-management technology to empower people living with cancer.

The iManageCancer team has created a cancer disease self-management platform designed according to the specific needs of patients and focusing on their wellbeing which features four apps and a personalised health record website. One of the tools incorporates the MASCC Risk Index.

Speakers

During the session the project Co-ordinator Stephan Kiefer (Fraunhofer Institute for Biomedical Engineering in St. Ingbert, Germany) will give an overview of the new services which have been developed and there will be a chance to try out the apps.

A pilot study has been running at the European Institute of Oncology (IEO) to evaluate the engagement of prostate and breast cancer patients with the tools and there will be a chance to hear from the IEO about the results from the pilot.

One of the goals of the IEO pilot was to understand the impact of the use of the tools on the psycho-emotional status of the patients. In addition, the pilot investigated whether implementation of a secure web-based platform in clinical practice improves value in terms of quality of life.

How the tools integrate MASCC risk stratification for febrile neutropenia

One of the tools developed by iManageCancer includes an app which will help patients at risk from febrile neutropenia communicate more effectively with their physician. The app integrates the MASCC risk stratification (also known as the MASCC Risk Index, a scoring system for identifying low-risk cancer patients with febrile neutropenia).

The patient receives regular notifications via the app for when to measure their temperature and if an increase is measured, receives advice to contact their physician who also receives the information.

The app for doctors can be used to select patients for testing more convenient or cost-effective therapies. It is a valuable part of the selection of patients who can safely be treated at home.